Picture loading failed.

Anti-Canine NGFB therapeutic antibody (Pre-made Bedinvetmab biosimilar,Canine Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Bedinvetmab is a canine monoclonal antibody (mAb) targeting Nerve Growth Factor (NGF). The inhibition of NGF mediated cell signalling has demonstrated to provide relief from pain associated with osteoarthritis. ... The presence of binding antibodies to bedinvetmab in dogs was assessed using a multitier approach.

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-052-1mg 1mg 3090
GMP-Bios-ab-052-10mg 10mg 21890
GMP-Bios-ab-052-100mg 100mg 148000
GMP-Bios-ab-052-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-Canine NGFB therapeutic antibody (Pre-made Bedinvetmab biosimilar,Canine Whole mAb)
INN Name Bedinvetmab
TargetCanine NGFB
FormatCanine Whole mAb
Species ReactivityCanine
CH1 IsotypeIgG2
VD LCLambda
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2018
Year Recommended2019
Conditions Approvedna
Conditions ActiveCanine lupus familiaris
Conditions Discontinuedna
Development Techna